Helen Torley, President and CEO at Halozyme Therapeutics, sold HALO on Aug 17, 2026
Data as of Oct 16
- Traded
- Aug 17, 2026
- Disclosed
- Aug 19, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
HALO since disclosure
+13.2%
after the sale
Similar stocks (XLV) since disclosure
+0.6%
XLV — its sector index fund
Change in closing price from Aug 19, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$345Kdisclosed Aug 19 · filed the same day
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$766Kdisclosed Aug 19 · filed the same day
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1Mdisclosed Aug 19 · filed the same day
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$510Kdisclosed Aug 19 · filed 1 day after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$588Kdisclosed Aug 19 · filed 1 day after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$986Kdisclosed Aug 19 · filed 1 day after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$214Kdisclosed Aug 19 · filed 2 days after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$776Kdisclosed Aug 19 · filed 2 days after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$50.2Kdisclosed Aug 19 · filed 2 days after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$923Kdisclosed Aug 19 · filed 2 days after the trade